Overview
The National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2026 (No. 5) is a technical amendment to the rules that govern how the Commonwealth pays for Pharmaceutical Benefits Scheme (PBS) medicines.
What this instrument amends
The amendment makes changes to the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019, also known as PB 114 of 2019. The changes are contained in Schedule 1 of the instrument. The source document does not specify which pricing figures or conditions were altered.
Key dates
- Registered: 29 May 2026
- In force from: 29 May 2026
- Repealed: 7 September 2026
Current status
This instrument is no longer in force. It was repealed on 7 September 2026. The current version of PB 114 of 2019 is available on the Federal Register of Legislation at legislation.gov.au.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.